Family Support, Social and Demographic Correlations of Non-Adherence among Haemodialysis Patients
American Journal of Nursing Science
Volume 4, Issue 2-1, March 2015, Pages: 60-65
Received: Dec. 21, 2014; Accepted: Dec. 23, 2014; Published: Jan. 23, 2015
Views 3316      Downloads 227
Authors
Alikari Victoria, Department of Nursing, University of Peloponnese, Sparta, Greece
Fradelos Evangelos, State Mental Hospital of Attica “Daphne”,Athens, Greece
Zyga Sofia, Department of Nursing, University of Peloponnese, Sparta, Greece
Article Tools
Follow on us
Abstract
Non-adherence to treatment is an increasing problem for patients with end stage renal disease under haemodialysis.Aim: This study aimed to review the basic literature mentioned to the correlation between haemodialysis patient demographic characteristics and non-adherence to their treatment regimen.Method: Studies written in English published in 2002-2013 were identified through PubMed, PubMed Central, Dove press, Scopus. Clinical trials and review articles were excluded. Key- words used for search included a combination of adherence / non-adherence and haemodialysis in titles. Results: According to the literature, patient demographic characteristics are important factors for patient adherence to treatment regimen. Generally, factors associated with increased level of non-adherence to haemodialysis treatment regimen included young age, sex, race and educational level. Conclusions: Early identification of risk factors, inclusion of patients in the health care team and participation in clinical decision making, can lead to behavior adherence.
Keywords
HaemodialysisPatient, Non-Adherence, Demographic Characteristics, Factors
To cite this article
Alikari Victoria, Fradelos Evangelos, Zyga Sofia, Family Support, Social and Demographic Correlations of Non-Adherence among Haemodialysis Patients, American Journal of Nursing Science. Special Issue:Mental Health Care: Aspects, Challenges and Perspectives. Vol. 4, No. 2-1, 2015, pp. 60-65. doi: 10.11648/j.ajns.s.2015040201.21
References
[1]
Centers for Disease Control and Prevention (CDC).Kidney Disease.Retreived from http: //www.cdc.gov./nchs/fastats/kidbladd.htm2013
[2]
Y. Kim, L. Evangelista, L. Phillips, C.Pavlish, andJ.Kopple, “The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ): testing the psychometric properties in patients receiving in-center haemodialysis,”NephrolNurs J 2010;37: 377-93.
[3]
M.Loghman- Adham,“Medication noncompliance in patients with chronic disease: Issues in dialysis and renal transplantation,” American Journal of Managed Care 2003; 9: 155-171
[4]
R. Saran, J. Bragg-Gresham, H.Rayner, D.Goodkin, M. Keen, and P. Van Dijk, “Non-adherence in haemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS,” Kidney Int 2003; 64: 254-62
[5]
http: //www.kidney.org/professionals/kdoqi/guidelines_commentaries.cfm (LAST ACCESSED September 2013)C.Kugler, I.Maeding, and C. Russell, “Non-adherence in patients on chronic haemodialysis: an international comparison study,” J Nephrol.2011; 24: 366-75.
[6]
M.Unruh, I. Evans, N. Fink, andN.Powe, “Skipped treatments, markers of nutritional non-adherence, and survival among incident haemodialysis patients,” Am J Kidney Dis 2005; 46: 1107-1116
[7]
F.Tentori, W. Hunt, andM.Rohrscheib,“Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?” J Am SocNephrol 2007; 18: 2377-2384
[8]
J.Kammerer, G. Garry, M.Hartigan,B. Carter, and L.Erlich,“Adherence in patients on dialysis: strategies for success,”NephrolNurs J 2007; 34: 479-86
[9]
E.Sabate, World Health Organization Meeting Report. Adherence to long- term therapies: policy for action. (www.int.chp/knowledge/publications/adherencerep.pdf) 2001
[10]
G. Reach, “A novel conceptual framework for understanding the mechanism of adherence to long term therapies,”Patient Prefer Adherence 2008 2; 2: 7-19.
[11]
P.Theofilou, “Factors affecting level of compliance in chronic patients,” J Int Med 2011; 2: 1-2
[12]
M Ginieri-Coccossis, P Theofilou, C Synodinou, V Tomaras, C Soldatos, “Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatment,” BMC Nephrol 2008; 9: 14
[13]
A.Covic, and A.Rastogi,“Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence,”BMC Nephrol 2013;14: 153.
[14]
S. Chow, and F. Wong,“Health-related quality of life in patients undergoing peritoneal dialysis: effects of a nurse-led case management programme,” J AdvNurs 2010; 66: 1780-92.
[15]
M. Martins, L. Silva, A.Kraychete, D. Reis, L. Dias, and G.Schnitman,“Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on haemodialysis,” BMC Nephrol 2013; 14: 208
[16]
J.Wiebe, and A. Christensen,”“Health beliefs, personality, and adherence in haemodialysis patients: an interactional perspective,” Ann Behav Med 1997; 19: 30-5.
[17]
P.Theofilou,“The effect of sociodemographic features and beliefs about medicines on adherence to chronic kidney disease treatment,” J Clin Res &Bioeth 2012; 3: 1-5
[18]
Z.Kauric-Klein, “Predictors of non-adherence with blood pressure regimens in haemodialysis,” Patient Prefer Adherence 2013; 23: 973-980
[19]
D.Hain, “Cognitive function and adherence of older adults undergoing haemodialysis,”NephrolNurs J 2008; 35: 23-29
[20]
A. Murray, “Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden,”Adv Chronic Kidney D 2008; 15: 123-132.
[21]
S.Baraz, S.Parvardeh, E.Mohammadi, and B.Broumand,“Dietary and fluid compliance: an educational intervention for patients having haemodialysis,” J AdvNurs 2010; 66(1): 60-8
[22]
R.Bland ,R. Cottrell, andL.Guyler, “Medication Compliance of Haemodialysis Patients and Factors Contributing to Non-Compliance,” Dialysis & Transplantation 2008; 37: 174–178
[23]
N.Safdar, H.Baakza, H. Kumar, and S.Naqvi, “Non-compliance to diet and fluid restrictions in haemodialysis patients,” J Pak Med Assoc. 1995; 45: 293-5.
[24]
M. Aldridge, “Writing and designing readable patient education materials,”NephrolNurs J 2004; 31: 373-377
[25]
T. Barnett ,T. Li Yoong, J.Pinikahana, and T. Si-Yen, “Fluid compliance among patients having haemodialysis: can an educational program make a difference?,”J AdvNurs 2008; 61: 300-6
[26]
Y. Chan, M.Zalilah, andS.Hii, “Determinants of compliance behaviours among patients undergoing haemodialysis in Malaysia,”PLoSOne 2012; 7: e41362.
[27]
P.Theofilou, “Medication adherence in Greek haemodialysis patients: the contribution of depression and health cognitions,’’Int J Behav Med 2013; 20: 311-8
[28]
H.Gimenes, M.Zanetti, and V. Haas, “Factors related to patient adherence to antidiabetic drug therapy,” Rev Lat Am Enfermagem.2009; 17: 46-51.
[29]
E. Song, D. Moser, and T.Lennie, “Relationship of depressive symptoms to the impact of physical symptoms on functional status in women with heart failure,” Am J Crit Care 2009; 18: 348-56.
[30]
L. Evangelista, D. Moser, C. Westlake, N.Pike, A.Ter-Galstanyan, andK.Dracup, “Correlates of fatigue in patients with heart failure,”ProgCardiovascNurs 2008; 23: 12-7.
[31]
M.Rambod, H.Peyravi, N.Shokrpour, and M.Sareban, “Dietary and fluid adherence in Iranian haemodialysis patients,” Health Care Manag (Frederick).2010; 29: 359-64.
[32]
M Zrinyi, M Juhasz, J Balla, E Katona, T Ben, “Dietary self-efficacy: determinant of compliance behaviours and biochemical outcomes in haemodialysis patients”Nephrol Dial Transplant 2003; 18: 1869-1873.
[33]
K. Smith, M.Coston, K.Glock, T.Elasy, and K.Wallston, “Patient Perspectives on Fluid Management in Chronic Haemodialysis,” J RenNutr 2010; 20: 334–341
[34]
C.Kugler, H. Vlaminck, A.Haverich, and B.Maes, “Non-adherence with diet and fluid restrictions among adults havinghaemodialysis,” J NursScholarsh 2005; 37: 25-9.
[35]
A Untas, J Thumma, N Rascle, H Rayner, D Mapes, “The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study,”Clin J Am SocNephrol 2011; 6: 142-52.
[36]
B. Kara, K .Caglar, and S.Kilic,“Non-adherence with diet and fluid restrictions and perceived social support in patients receiving haemodialysis,” J NursScholarsh 2007; 39: 243–248
[37]
A. Christensen, T. Smith, C Turner, J.Jr Holman, and M.Gregory,“Family support, physical impairment, and adherence in haemodialysis: An investigation of main and buffering effects”J Behav Med 1992; 15: 313–325
[38]
R. Jindal, J.Joseph, M. Morris, R.Santella, and L. Baines, “Noncompliance after kidney transplantation: a systematic review,” Transplant Proc 2003; 35: 2868–2872.
[39]
R.Julius, M.Novitsky, and W.Dubin, “Medication adherence: a review of the literature and implications for clinical practice,” J PsychiatrPract 2009; 15: 34–44.
[40]
S.Pampallona, P.Bollini, G.Tibaldi, B.Kupelnick, and C.Munizza, “Patient adherence in the treatment of depression,” Br J Psychiatry 2002; 180: 104–109.
[41]
M.DiMatteo, “Social support and patient adherence to medical treatment: a meta-analysis,” Health Psychol 2004; 23: 207–218
[42]
C.Karamanidou, J.Clatworthy, J.Weinman, andR. Horne, “A systematic review of the prevalence and determinants of non-adherence to phosphate binding medication in patients with end-stage renal disease,” BMC Nephrol2008; 9: 2
[43]
E.Vermeire, H.Hearnshaw, P.VanRoyen, and J.Denekens, “Patient adherence to treatment: three decades of research. A comprehensive review,” J Clin Pharm Ther 2001; 26: 331–342
[44]
S.Bame, N. Petersen, and N. Wray,“Variation in haemodialysis patient compliance according to demographic characteristics,”SocSci Med 1993; 37: 1035-43.
[45]
J.JrLeggat, S.Orzol, T. Hulbert-Shearon, T.Golper, and C.Jones, “Noncompliance in haemodialysis: predictors and survival analysis,” Am J Kidney Dis 1998; 32: 139-45.
[46]
N.Kutner, R. Zhang ,W. McClellan, and S. Cole, “Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients,”Nephrol Dial Transplant2002; 17: 93-9
[47]
J. Jin, G.Sklar, V.Min SenOh, and S.Chuen Li, “Factors affecting therapeutic compliance: A review from the patient's perspective,”TherClin Risk Manag 2008;4: 269-86.
[48]
L.Raiz, K.Kilty, M. Henry, and R. Ferguson, “Medication compliance following renal transplantation,’’ Transplantation 1999; 68: 51-5.
[49]
L. Thomas, R. Sargent, P.Michels, D. Richter, andR. Valois,“Identification of the factors associated with compliance to therapeutic diets in older adults with end stage renal disease,” J RenNutr 2001; 11: 80-9.
[50]
R.Curtin, B.Svarstad, and T. Keller, “Haemodialysis patients’ noncompliance with oral medications,” ANNA J 1999; 26: 307-316.
[51]
S. De Geest, L.Borgermans, H.Gemoets,I. Abraham ,andH.Vlaminck, “Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients” Transplantation 1995; 59: 340–7.
[52]
P.Frazier, S. Davis-Ali,and K. Dahl,“Correlates of noncompliance among renal transplant recipients,”Clin Transplant 1994; 8: 550–7.
[53]
A.Yavuz, M.Tuncer, O.Erdogan, A.Gürkan,andR.Cetinkaya, “Is there any effect of compliance on clinical parameters of renal transplant recipients?,” Transplant Proc 2004; 36: 120–1.
[54]
A.Ghods,andD.Nasrollahzadeh, “Noncompliance with immunnosuppressive medications after renal transplantation,”ExpClin Transplant2003; 1: 39–47.
[55]
F.Spikmans, J.Brug, M.Doven, H.Kruizenga, and G.Hofsteenge, “Why do diabetic patients not attend appointments with their dietitian?,” J Hum Nutr Diet 2003; 16: 151–8.
[56]
A.Tezel, E.Karabulutlu, and O.Sahin, “Depression and perceived social support from family in Turkish patients with chronic renal failure treated by haemodialysis,” J Res Med Sci 2011; 16: 666-73.
[57]
J. Grierson, M.Bartos,R. De Visser,andK. McDonald, “HIV future II. The health and well-being of people with HIV/AIDS in Australia,” La Trobe University,2000.
[58]
T. Browne, and J.Merighi, “Barriers to adult haemodialysis patients' self-management of oral medications,” Am J Kidney Dis 2010; 56: 547-57.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186